Drug details

Tyzeka (telbivudine)

type of Hepatitis B, NRTIs

Tyzeka (telbivudine) is an antiviral medication used to treat chronic hepatitis B in adults. Tyzeka will not cure hepatitis.

This drug may have the following side effects:

• nausea
• dizziness
• vomiting
• diarrhea
•  joint pain
•  headache
• sore throat
• cough
• low fever
• sleep problems (insomnia)
• bloating
• tiredness
• muscle aches
• itching or mild skin rash
• back pain, or

The following drugs are related to Tyzeka, either as a replacement or used together:

• Engerix-B (hepatitis b vaccine recombinant)
• Epivir (lamivudine)
• Epivir-HBV (lamivudine tablets and oral solution)
• Mavyret (glecaprevir and pibrentasvir)
• Havrix (hepatitis a vaccine, inactivated)
• Vaqta (hepatitis a vaccine, inactivated)
• Recombivax (hepatitis b vaccine (recombinant))
• PreHevbrio (hepatitis b vaccine (recombinant) injectable suspension)
• Roferon-A (interferon alfa-2a, recombinant)
• Intron A (interferon alfa-2b, recombinant for injection)